Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | +8.00% | +8.00% | +10.66% |
2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
Sales 2021 | 1.16B 160M | Sales 2022 | 1.24B 172M | Capitalization | 2.97B 410M |
---|---|---|---|---|---|
Net income 2021 | 508M 70.12M | Net income 2022 | 501M 69.16M | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 838M | Net cash position 2022 | 6.66B 919M | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | 1,202 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
1 day | +8.00% | ||
1 week | +8.00% | ||
1 month | -10.00% | ||
3 months | +8.00% | ||
6 months | +9.76% | ||
Current year | +10.66% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 04-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 08-12-31 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Director/Board Member | 56 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 1.35 | +8.00% | 3,733 |
Delayed Quote OTC Markets, April 22, 2024 at 01:29 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+10.66% | 181M | |
-11.82% | 87.77B | |
+14.64% | 82.08B | |
+13.31% | 30.03B | |
-10.66% | 17.08B | |
-5.65% | 14.45B | |
+2.20% | 12.37B | |
-31.05% | 11.89B | |
+2.69% | 12.17B | |
+26.50% | 11.62B |
- Stock Market
- Equities
- CORBF Stock